Skip to main content
SpringerLink
Log in

Modification of Albumin Use Pattern After an Educational Intervention

  • Original Research Article
  • Published:
Disease Management and Health Outcomes

Abstract

Objective: To determine whether an educational programme could reduce the inappropriate use of albumin.

Study design and setting: A hospital albumin working group (San Carlos Clinical Hospital, Madrid, Spain) developed local guidelines for albumin prescribing. After the guidelines were disseminated, all albumin prescriptions were analysed according to these guidelines. Physicians who prescribed albumin for indications other than those in the guidelines were selected for a personalised face-to-face educational programme with a clinical pharmacologists. Adherence to the guidelines was then evaluated compared with an observational period with success being measured in terms of quality of prescribing and economic consequences. The effects of the intervention were assessed again during the intervention (7 months) and after the intervention (in the first 5-month period and in the subsequent year).

Main outcomes measures and results: In the observational period, consumption was centralised in medical services and nearly 76% of prescriptions for albumin were inappropriate. During the intervention, the percentage of inappropriate albumin prescribing decreased to 38.8%. Albumin consumption decreased from 444 vials/month during the observational period to 249 vials/month during the intervention, and although the average monthly consumption increased slightly during the 17 months following the intervention, it was similar to that immediately after the intervention.

Differences in albumin consumption and quality improvement between the observational period and during the intervention were statistically significant (p < 0.00001). These results led to cost savings of nearly 30% during the intervention and in the follow-up period.

Conclusions: This educational programme improved the quality of albumin prescribing and controlled local expenses related to albumin use in a general hospital.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Table IV

Similar content being viewed by others

References

  1. Gianarkis DF, Kucich JM, Liotta CA. Evaluating albumin usage in an urban acute care hospital. Hosp Pharm 1991; 26: 434–6

    PubMed  CAS  Google Scholar 

  2. Yim J, Vermeulen LC, Erstad B, et al. Albumin and nonprotein colloid solution use in US academic health centers. Arch Intern Med 1995; 155: 2450–5

    Article  PubMed  CAS  Google Scholar 

  3. Alexander MR, Alexander B, Mustion AL, et al. Therapeutic use of albumin. JAMA 1982; 247: 831–3

    Article  PubMed  CAS  Google Scholar 

  4. Alexander MR, Stumpf JL, Nostrant TT, et al. Albumin utilization in a university hospital. DICP Ann Pharmacother 1989; 23: 214–7

    CAS  Google Scholar 

  5. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998; 317: 235–40

    Article  Google Scholar 

  6. Vermeulen L, Ratko TA, Erstad BL, et al. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid and crystalloid solutions. Arch Intern Med 1995; 155: 373–9

    Article  PubMed  Google Scholar 

  7. Erstad BL, Gales BJ, Rappaport WD. The use of albumin in clinical practice. Arch Intern Med 1991; 151: 901–1

    Article  PubMed  CAS  Google Scholar 

  8. Subcommittee of the Victorian Drug Usage Advisory Committee. Human albumin solutions: consensus statements for use in selected clinical situations. Med J Aust 1992; 157: 340–2

    Google Scholar 

  9. Mangues Y, Lloberas N, Ferrer MI, et al. Criterios de utilización de albúmina. Farm Clin 1995; 12: 271–7

    Google Scholar 

  10. Gales B. Albumin audit results and guidelines for use. J Pharm Technol 1992; 8: 125–9

    PubMed  CAS  Google Scholar 

  11. Ginés P, Arroyo V, Quintero E, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascitis. Gastroenterology 1987; 93: 234–41

    PubMed  Google Scholar 

  12. Ginés P, Titó LL, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without albumin in cirrhosis. Gastroenterology 1988; 94: 1493–502

    PubMed  Google Scholar 

  13. Du Grés B, Gruner MC, Flamens C. Comparaison des effects hémodynamiques de lHaemaccel et de lálbumine dilueé dans le période postopératoire immédiate aprés chirugie cardiaque. Cah Anestesiol 1989; 37: 327–32

    Google Scholar 

  14. Chesta J, Brahm J, Latorre R, et al. Paracentesis con infusión de albúmina en el tratamiento de la ascitis a tensión en pacientes cirróticos. Rev Med Chile 1990; 118: 874–80

    PubMed  CAS  Google Scholar 

  15. Vargas E, De Miguel V, Portalés A, et al. Use of albumin in two Spanish hospitals. Eur J Clin Pharmacol 1997; 52: 465–70

    Article  PubMed  CAS  Google Scholar 

  16. Fineberg HV. Technology assessment. Motivation, capability, and future decisions. Med Care 1985; 23(5): 663–71

    Article  PubMed  CAS  Google Scholar 

  17. Soumerai SB, McLaughlin TJ, Avorn J. Quality assurance for drug prescribing. Qual Assur Health Care 1990; 2(1): 37–58

    Article  PubMed  CAS  Google Scholar 

  18. Stratton TP, Plachetka JR, Gaines JA. Cost savings from hetastarch use in place of albumin on a cardiothoracic surgery service. Hosp Formul 1984; 19: 571–83

    PubMed  CAS  Google Scholar 

  19. Hicks GL, Jensen LA, Norsen LH, et al. Platelet inhibitors and hydroxyethyl starch: Safe and cost-effective interventions in coronary artery surgery. Ann Thorac Surg 1985; 39: 422–5

    Article  PubMed  Google Scholar 

  20. Stumpf J, Lechner JL, Ryan M. Use of albumin in a university hospital: the value of targeted physician intervention. Ann Pharmacother 1991; 25: 239–43

    CAS  Google Scholar 

  21. Anonymous. Albumin/Hetastarch guideline targets appropriate use, results in reduced product expenditures. Formulary 1998; 33: 905–6

  22. Wong YY, Abramowitz PW, Mansur JM. Changing use patterns of plasma volume expanders through educational intervention. Am J Hosp Pharm 1987; 44: 102–5

    PubMed  CAS  Google Scholar 

  23. Avorn JL, Soumerai SB, Taylor W, et al. Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med 1988; 148: 1720–4

    Article  PubMed  CAS  Google Scholar 

  24. Avorn JL, Soumerai SB. Improving drug therapy decisions through educational outreach: a randomized controlled trial of academically-based detailing. N Engl J Med 1983; 308: 1457–63

    Article  PubMed  CAS  Google Scholar 

  25. Eisenberg JM, Williams SV. Cost containment and changing physicians’ practice behavior. Can the fox learn to guard the chicken coop? JAMA 1981; 246: 2195–201

    Article  PubMed  CAS  Google Scholar 

  26. Schroeder SA, Myers LP, McPhee SJ, et al. The failure of physician education as cost containment strategy. JAMA 1984; 252: 225–30

    Article  PubMed  CAS  Google Scholar 

  27. Soumerai SB, Avorn J. Predictors of physician prescribing change in an educational experiment to improve medication use. Med Care 1987; 25(3): 210–221

    Article  PubMed  CAS  Google Scholar 

  28. Acosta PJ, Sánchez A, Tarín MJ. Análisis de 1a utilización de albúmina en los hospitales de la Comunidad Autónoma Andaluza. Inf Ter Sis Nac Salud 1997; 21: 73–81

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servicio de Farmacología Clínica, Hospital Universitario San Carlos, C/Martín Lagos s/n, Madrid, 28040, Spain

    Veronica De Miguel,  Emilio Vargas (Physician, Associate Professor), Antonio Portoles, Miguel Puerro, Ana Isabel Terleira & Alfonso Moreno

Authors
  1. Veronica De Miguel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emilio Vargas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Portoles
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Miguel Puerro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana Isabel Terleira
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alfonso Moreno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emilio Vargas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Miguel, V., Vargas, E., Portoles, A. et al. Modification of Albumin Use Pattern After an Educational Intervention. Dis-Manage-Health-Outcomes 8, 43–50 (2000). https://doi.org/10.2165/00115677-200008010-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200008010-00005

Keywords

Search

Navigation